Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Sponsor
Fudan University
Study ID
NCT04912258
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Trans arterial chemoembolization using Irinotecan Drug-eluting Beads before liver surgery for patients with primarily unresectable colorectal liver metastasis

Key Dates

Start date
Aug 1, 2021
Status verified
Mar 2021
Primary completion
Dec 1, 2022
Completion
Jun 1, 2023

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A
    DEB-TACE before liver surgery
  • No Intervention: Arm B
    direct liver surgery

Primary Outcome Measure

liver relapse-free survival [ Time Frame: 6 months ]

Central Contacts

Related Studies